Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

Clinical trial NCT06443034 · UNKNOWN

Trial details

NCT number: NCT06443034
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Study type: OBSERVATIONAL

Nephrotic Syndrome Focal Segmental Glomerulosclerosis APOL1 Associated Kidney Disease

Start date: 2024-06-30
Primary completion: 2024-12-30
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.